Humacyte, Inc. Common Stock (NASDAQ: HUMA) last traded at $0.642, down 5.75% on the session. The quote above updates while this page is open; the figures below are drawn from Humacyte, Inc. Common Stock’s own filings and are restated only when a new one is published.
Humacyte, Inc. Common Stock trades on NASDAQ under the ticker HUMA. Its market capitalisation is $178.40 million.
Valuation measures for Humacyte, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $178.40M |
|---|---|
| Enterprise value | $205.32M |
| Price / sales | 84.11 |
| Price / book | 5.71 |
| Beta | 3.17 |
Trailing-twelve-month figures tagged in Humacyte, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $2.12M |
|---|---|
| Net income (TTM) | -$96.73M |
| Operating margin | -5240.78% |
| Return on equity | -309.44% |
| Cash | $79.90M |
Range and volume for HUMA over the past 52 weeks.
| 52-week high | $2.55 |
|---|---|
| 52-week low | $0.526 |
| Volume | 9.36M |
| Average volume | 11.14M |
| Previous close | $0.681 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.